Protein kinase C-α coordinately regulates cytosolic phospholipase A2 activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes

Molecular Pharmacology

Volumn 59, Issue 4, 2001, Pages 860-866

  Wang, Hui Qin ^a   Kim, Michael P ^a   Tiano, Howard F ^b   Langenbach, Robert ^b   Smart, Robert C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CYCLOOXYGENASE 2; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE A2; PROTEIN KINASE C;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN DISEASE; SKIN INFLAMMATION; TRANSGENIC MOUSE;

EID: 0035060426     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.4.860     Document Type: Article

References (47)

1. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway
2. 2 in platelets is mediated by multiple stress-activated protein kinase pathways
3. 2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets
4. COX-2 expression is induced by UVB exposure in human skin: Implications for the development of skin cancer
5. 2
6. COX-1 and COX-2 tissue expression: Implications and predictions
7. Over-expression of protein kinase C-alpha enhances platelet-derived growth factor- and phorbol ester-but not calcium ionophore-induced formation of prostaglandins in NIH 3T3 fibroblast
8. Prostaglandins and cancer
9. 2
10. 2 from cytosol to the nuclear envelope in rat basophilic leukemia cells stimulated with calcium ionophore or IgE/antigen
11. Inhibition of expression of protein kinase C alpha by antisense cDNA inhibits phorbol ester-mediated arachidonate release
12. 2 by p42 mitogen-activated protein kinase results in an increase in specific activity
13. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2
14. 2 and arachidonic acid release in cultured cat iris sphincter smooth muscle cells
15. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element
16. Transcriptional role of the nuclear factor kappa B site in the induction by lipopolysaccharide and suppression by dexamethasone of cyclooxygenase-2 in U937 cells
17. How is the level of free arachidonic acid controlled in mammalian cells?
18. Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues
19. Protein kinase C alpha activates RAF-1 by direct phosphorylation
20. Cyclooxygenase knockout mice: Models for elucidating isoform-specific functions
21. 2 is phosphorylated and activated by MAP kinase
22. 2 alters keratinocyte prostaglandin synthesis, growth, and apoptosis
23. Prostaglandin synthase 2 expression in epidermal growth factor-dependent proliferation of mouse keratinocytes
24. Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes
25. Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases
26. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
27. Retinoids suppress epidermal growth factor-induced transcription of cyclooxygenase-2 in human oral squamous carcinoma cells
28. 2 by p42 microtubule-associated protein 2 kinase and protein kinase C
29. alpha-1-adrenergic receptor stimulation causes arachidonic acid release through pertussis toxin-sensitive GTP-binding protein and JNK activation in rabbit aortic smooth muscle cells
30. Expression of CCAAT/enhancer binding proteins (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms
31. Transgenic mice overexpressing protein kinase Cδ in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13acetate
32. Transgenic mice overexpressing protein kinase C ε in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion
33. Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells
34. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation
35. 2 to the nuclear envelope and endoplasmic reticulum
36. Prostaglandin endoperoxide H synthases-1 and -2
37. An essential role for C/EBPβ in female reproduction
38. Transactivation by NF-IL6/LAP is enhanced by phosphorylation of its activation domain
39. Overexpression of protein kinase C-α in the epidermis of transgenic mice results in striking alterations in phorhol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion
40. 2 are abrogated by an inhibitor of the p38 mitogen-activated protein kinase cascade in human neutrophils
41. 2 in human neutrophils stimulated with tumor necrosis factor-alpha
42. v-src induces prostaglandin synthase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor
43. Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum
44. 2 and mitogen-activated protein kinase by alpha 1-adrenergic receptors in Madin-Darby canine kidney cells
45. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells
46. Transcriptional regulation of cyclooxygenase-2 gene expression: Novel effects of nonsteroidal anti-inflammatory drugs